经导管动脉化疗栓塞治疗肝细胞癌后mRECIST测量与疗效评估的可重复性
回顾性评估97例肝细胞癌患者TACE(60例传统TACE、37例药物洗脱微球TACE)后基于mRECIST的多期CT疗效评估可重复性。四位放射科医师评估,总体反应观察者内可重复性中等至优秀(κ=0.525-0.865),观察者间第二次评估较第一次改善且两组均良好(cTACE κ=0.627,DEB-TACE κ=0.602),cTACE后略优于DEB-TACE。靶病灶选择一致率在靶病灶反应一致的病例中显著更高(P=.003)。
要点
- mRECIST评估HCC TACE后疗效的观察者内可重复性为中等至优秀(κ=0.525-0.865)。
- 观察者间可重复性第二次评估较第一次改善,cTACE组κ=0.627,DEB-TACE组κ=0.602。
- 靶病灶反应一致时靶病灶选择一致率显著更高(P=.003)。
核心结论
- HCC患者TACE后mRECIST的观察者内和观察者间可重复性为中等至优秀,cTACE后略优于DEB-TACE。
研究设计与样本
- 回顾性研究,纳入2010至2014年接受TACE的97例HCC患者(60例cTACE,37例DEB-TACE),四位放射科医师基于mRECIST评估TACE前后2个月内动态肝脏CT配对图像。
诊断标准与关键数值
- 总体反应观察者内可重复性κ=0.525-0.865。
- 观察者间可重复性第二次评估较第一次改善,cTACE组κ=0.627,DEB-TACE组κ=0.602。
- 长径总和测量的组内相关系数显示观察者内和观察者间可重复性优秀。
- 靶病灶选择一致率在放射科医师靶病灶反应一致的病例中显著高于反应不一致的病例(P=.003)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the reproducibility of Modified Response Evaluation Criteria in Solid Tumors (mRECIST) for hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) using multiphasic computed tomography.
MATERIALS AND METHODS: The institutional review board approved this retrospective study. We evaluated 97 patients who underwent TACE (60 conventional TACE [cTACE] and 37 drug-eluting bead TACE [DEB-TACE]) for HCC from 2010 to 2014. Four radiologists evaluated pairs of dynamic liver CTs scanned within 2 months before and after TACE based on mRECIST. Assessment of intra- or interobserver reproducibility for response categorization and sum of long diameter were evaluated using weighted kappa statistics (κ) and intraclass correlation coefficients, respectively. The relationship between concordance of target lesion selection and agreement of target lesion response was evaluated using Fisher exact test.
RESULTS: Intraobserver reproducibility for overall response was moderate to excellent (κ = 0.525-0.865). Interobserver reproducibility was improved on the second review compared to the first review and it was good in both treatment groups (κ = 0.627 for cTACE and 0.602 for DEB-TACE). Between the two treatment methods, intra- or interobserver reproducibility was better after cTACE than DEB-TACE. Intraclass correlation coefficients for sum of long diameter measurement showed excellent intra- or interobserver reproducibility. The concordance rate of target lesion selection was significantly higher for patients with radiologists' agreement for target lesion response than patients with disagreed response (P = .003).
CONCLUSIONS: The intra- and interobserver reproducibility of mRECIST in patients with HCC after TACE was moderate to excellent, and the reproducibility was slightly better after cTACE than DEB-TACE.
引用
- Choi MH, Park GE, Oh SN, et al. Reproducibility of mRECIST in Measurement and Response Assessment for Hepatocellular Carcinoma Treated by Transarterial Chemoembolization. Acad Radiol. 2018. PMID: 29555570. doi:10.1016/j.acra.2018.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。